Expect Equity LLC Buys New Position in The Cooper Companies, Inc. $COO

Expect Equity LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 42,050 shares of the medical device company’s stock, valued at approximately $3,015,000. Cooper Companies makes up approximately 1.9% of Expect Equity LLC’s portfolio, making the stock its 19th biggest holding.

A number of other institutional investors and hedge funds also recently bought and sold shares of COO. Legal & General Group Plc acquired a new stake in shares of Cooper Companies during the second quarter worth about $60,521,000. The Manufacturers Life Insurance Company acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $69,129,000. Sone Capital Management LLC acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $27,754,000. Trajan Wealth LLC purchased a new stake in Cooper Companies during the 2nd quarter worth approximately $19,348,000. Finally, Manning & Napier Advisors LLC purchased a new stake in Cooper Companies during the 2nd quarter worth approximately $107,939,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

More Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research report on Wednesday, May 27th. UBS Group assumed coverage on Cooper Companies in a report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price for the company. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Finally, Robert W. Baird cut their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Cooper Companies presently has a consensus rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Performance

Shares of COO stock opened at $73.04 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The firm has a fifty day moving average price of $72.20 and a 200 day moving average price of $71.01. The company has a market cap of $14.24 billion, a P/E ratio of 61.90, a PEG ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.